MCA
ABBV icon

MSH Capital Advisors’s AbbVie ABBV Stock Holding History

MSH Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Sell
12,670
-4,833
-28% -$1.07M 0.58% 46
2025
Q4 		$4M Buy
17,503
+8,934
+104% +$2.04M 0.85% 28
2025
Q3 		$1.98M Sell
8,569
-95
-1% -$19.3K 0.53% 57
2025
Q2 		$1.61M Sell
8,664
-77
-0.9% -$14.3K 0.46% 65
2025
Q1 		$1.83M Sell
8,741
-141
-2% -$27.4K 0.57% 53
2024
Q4 		$1.58M Sell
8,882
-314
-3% -$57.7K 0.5% 61
2024
Q3 		$1.82M Sell
9,196
-271
-3% -$50.6K 0.56% 58
2024
Q2 		$1.62M Sell
9,467
-210
-2% -$34.8K 0.54% 59
2024
Q1 		$1.76M Sell
9,677
-344
-3% -$59.3K 0.62% 54
2023
Q4 		$1.55M Sell
10,021
-381
-4% -$55.5K 0.58% 57
2023
Q3 		$1.55M Sell
10,402
-479
-4% -$70.3K 0.61% 54
2023
Q2 		$1.47M Buy
10,881
+234
+2% +$34.3K 0.54% 64
2023
Q1 		$1.7M Sell
10,647
-374
-3% -$57.2K 0.72% 44
2022
Q4 		$1.78M Sell
11,021
-78
-0.7% -$12K 0.8% 38
2022
Q3 		$1.49M Sell
11,099
-479
-4% -$68.7K 0.73% 47
2022
Q2 		$1.77M Buy
11,578
+356
+3% +$54.4K 0.82% 39
2022
Q1 		$1.82M Buy
11,222
+599
+6% +$87K 0.75% 41
2021
Q4 		$1.44M Buy
+10,623
New +$1.25M 0.64% 50

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSH Capital Advisors's ABBV Position: Q1 2026 in Review

MSH Capital Advisors reduced its AbbVie (ABBV) stake by 28% in Q1 2026, selling an estimated $1.07M and leaving 12,670 shares worth $2.76M. The position accounts for 0.58% of the portfolio, ranked #46.

MSH Capital Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $4M in Q4 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • MSH Capital Advisors held 12,670 shares of AbbVie worth $2.76M as of Q1 2026.
  • MSH Capital Advisors sold 4,833 AbbVie shares in Q1 2026, an estimated $1.07M.
  • AbbVie made up 0.58% of MSH Capital Advisors's portfolio in Q1 2026, its #46 holding.
  • MSH Capital Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • MSH Capital Advisors's AbbVie position peaked at $4M in Q4 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on MSH Capital Advisors's 13F filing for Q1 2026, filed 11 May 2026.